GTCR and Recognize to Acquire TRANZACT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Willis Towers Watson (WTW) PT Raised to $334 at Wells Fargo
October 3, 2024 5:57 AM EDTWells Fargo analyst Jared Shaw raised the price target on Willis Towers Watson (NASDAQ: WTW) to $334.00 (from $321.00) while maintaining a Overweight rating.
The analyst comments "Supportive of our tactical call/additional catalysts for WTW: This deal is helpful to our tactical... More
Willis Towers Watson (WTW) PT Raised to $345 at Roth/MKM
October 2, 2024 6:15 AM EDTRoth/MKM analyst Harry Fong raised the price target on Willis Towers Watson (NASDAQ: WTW) to $345.00 (from $315.00) while maintaining a Buy rating.
The analyst comments "WTW announced an agreement to sell its Tranzact business to GTCR, a private equity firm, for $632.4... More
